SERB
1 known investors
SERB is a pharmaceutical company specializing in rare diseases and emergency medicine, with a portfolio of 70+ medicines including antidotes for chemical, biological, radiological and nuclear threats. The company serves hospitals, healthcare systems, first responders, and patients with rare conditions in oncology, neurology, and metabolic disorders across 100+ countries.
Investors Β· 1
Frequently asked questions
- What does SERB do?
- SERB is a pharmaceutical company specializing in rare diseases and emergency medicine, with a portfolio of 70+ medicines including antidotes for chemical, biological, radiological and nuclear threats. The company serves hospitals, healthcare systems, first responders, and patients with rare conditions in oncology, neurology, and metabolic disorders across 100+ countries.
- Who are SERB's investors?
- SERB's investors include Charterhouse Capital Partners.